Amlodipine and Graft versus host disease in skin - a phase IV clinical study of FDA data

Summary:

Graft versus host disease in skin is found among people who take Amlodipine, especially for people who are male, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Amlodipine and have Graft versus host disease in skin. It is created by eHealthMe based on reports of 285,218 people who have side effects when taking Amlodipine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 19, 2022

285,218 people reported to have side effects when taking Amlodipine.
Among them, 13 people (0.0%) have Graft versus host disease in skin.


What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 291,845 Amlodipine users for its effectiveness, alternative drugs and more.

What is Graft versus host disease in skin?

Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin) is found to be associated with 279 drugs and 176 conditions by eHealthMe.

Number of Amlodipine and Graft versus host disease in skin reports submitted per year:

Could Amlodipine cause Graft versus host disease in skin?

Time on Amlodipine when people have Graft versus host disease in skin *:

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Graft versus host disease in skin when taking Amlodipine *:

  • female: 30 %
  • male: 70 %

Age of people who have Graft versus host disease in skin when taking Amlodipine *:

  • 0-1: 0.0 %
  • 2-9: 10 %
  • 10-19: 10 %
  • 20-29: 20 %
  • 30-39: 0.0 %
  • 40-49: 20 %
  • 50-59: 40 %
  • 60+: 0.0 %

Common drugs people take besides Amlodipine *:

  1. Posaconazole: 5 people, 38.46%
  2. Symbicort: 3 people, 23.08%
  3. Jakafi: 3 people, 23.08%
  4. Pantoprazole: 3 people, 23.08%
  5. K-Tab: 3 people, 23.08%
  6. Lovenox: 3 people, 23.08%
  7. Protonix: 3 people, 23.08%
  8. Revlimid: 3 people, 23.08%
  9. Diflucan: 3 people, 23.08%
  10. Omega 3: 3 people, 23.08%

Common side effects people have besides Graft versus host disease in skin *:

  1. Thrombocytopenia (decrease of platelets in blood): 7 people, 53.85%
  2. Anaemia (lack of blood): 5 people, 38.46%
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 30.77%
  4. Pneumonia: 4 people, 30.77%
  5. Nosebleed (bleeding from nose): 3 people, 23.08%
  6. Fractured Sacrum: 3 people, 23.08%
  7. Enterococcal Infection: 3 people, 23.08%
  8. Weight Decreased: 3 people, 23.08%
  9. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 23.08%
  10. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 23.08%

Common conditions people have *:

  1. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 23.08%
  2. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 23.08%
  3. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 23.08%
  4. Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 3 people, 23.08%
  5. Bone Marrow Conditioning Regimen: 2 people, 15.38%
  6. Fever: 1 person, 7.69%
  7. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 7.69%
  8. Adenovirus Infection: 1 person, 7.69%
  9. Constipation: 1 person, 7.69%
  10. Diarrhea: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Graft versus host disease in skin?

Check whether Graft versus host disease in skin is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Graft versus host disease in skin and when was it recovered:

Expand to all the drugs that have ingredients of amlodipine besylate:

Alternative drugs to, pros and cons of Amlodipine:

Common Amlodipine side effects:

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Graft versus host disease in skin treatments and more:

COVID vaccines that are related to Graft versus host disease in skin:

Common drugs associated with Graft versus host disease in skin:

All the drugs that are associated with Graft versus host disease in skin:

Common conditions associated with Graft versus host disease in skin:

All the conditions that are associated with Graft versus host disease in skin:

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: